These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23919474)

  • 1. Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.
    El-Gendy N; Kaviratna A; Berkland C; Dhar P
    Ther Deliv; 2013 Aug; 4(8):951-80. PubMed ID: 23919474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous surfactant replacement: how to deliver it?
    Biban P; Chini L; Bonetti P; Sacco F; Zaglia F; Santuz P
    Acta Biomed; 2012; 83 Suppl 1():27-32. PubMed ID: 23029874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant therapy of pulmonary conditions excluding those with primary surfactant deficiency and bronchoscopy as delivery method: an overview of Russian patents and publications.
    Jargin SV
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):134-7. PubMed ID: 23157179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Surfactant Therapy and Noninvasive Respiratory Support.
    Kribs A
    Clin Perinatol; 2016 Dec; 43(4):755-771. PubMed ID: 27837757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal studies of surfactant replacement therapy.
    Lachmann B
    Dev Pharmacol Ther; 1989; 13(2-4):164-72. PubMed ID: 2692999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
    Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
    Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovation in surfactant therapy II: surfactant administration by aerosolization.
    Pillow JJ; Minocchieri S
    Neonatology; 2012; 101(4):337-44. PubMed ID: 22940623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement therapy with porcine natural surfactant--current status and future challenges. Report from the 8th International Workshop on Surfactant Replacement, Oslo, May 20-22, 1993.
    Saugstad OD; Halliday HL; Robertson B; Speer CP
    Biol Neonate; 1993; 64(5):269-78. PubMed ID: 7905289
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of exogenous surfactant therapy.
    Willson DF; Notter RH
    Respir Care; 2011 Sep; 56(9):1369-86; discussion 1386-8. PubMed ID: 21944686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bases of the replacement surfactant therapy for bronchopulmonary diseases].
    Zagorul'ko AK; Kliaritskaia IL
    Lik Sprava; 2004; (5-6):79-86. PubMed ID: 15605831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the interaction of particulate delivery systems with lung surfactant.
    Wiedmann TS
    Methods Mol Med; 2003; 75():755-69. PubMed ID: 12407777
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways.
    Goikoetxea E; Murgia X; Serna-Grande P; Valls-i-Soler A; Rey-Santano C; Rivas A; Antón R; Basterretxea FJ; Miñambres L; Méndez E; Lopez-Arraiza A; Larrabe-Barrena JL; Gomez-Solaetxe MA
    PLoS One; 2014; 9(9):e106835. PubMed ID: 25211475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
    Joshi N
    Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
    [No Abstract]   [Full Text] [Related]  

  • 18. Expanded use of surfactant therapy in newborns.
    Lacaze-Masmonteil T
    Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant replacement therapy for pulmonary diseases.
    Pramanik AK; Holtzman RB; Merritt TA
    Pediatr Clin North Am; 1993 Oct; 40(5):913-36. PubMed ID: 8414715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded use of surfactant replacement therapy.
    Greenough A
    Eur J Pediatr; 2000 Sep; 159(9):635-40. PubMed ID: 11014460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.